Investing.com - Itamar Medical reported on Tuesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Itamar Medical announced earnings per share of $-0.01 on revenue of $8.89M. Analysts polled by Investing.com anticipated EPS of $-0.19 on revenue of $7.81M.
Itamar Medical shares are up 75.06% from the beginning of the year and are trading at $22.53 , down-from-52-week-high.They are outperforming the Nasdaq which is up 21.05% from the start of the year.
Itamar Medical shares lost 12.88% in intra-day trade after the report.
Itamar Medical follows other major sector earnings this month
Itamar Medical's report follows an earnings beat by L’Oreal ADR on Thursday, July 30, 2020, who reported EPS of $3.82 on revenue of $6.92B, compared to forecasts EPS of $0.85 on revenue of $6.98B.
SoftBank Group had beat expectations on Tuesday with second quarter EPS of $2.91 on revenue of $13.71B, compared to forecast for EPS of $0.02 on revenue of $13.96B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar